Emergent BioSolutions
EBS
#6699
Rank
โ‚น59.33 B
Marketcap
โ‚น1,112
Share price
0.98%
Change (1 day)
60.66%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2025 (TTM): โ‚น14.36 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are โ‚น0.75 Billion. In 2024 the company made an earning of -โ‚น6.44 Billion, an increase over its 2023 earnings that were of -โ‚น57.61 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น14.36 B-323.16%
2024 -โ‚น6.44 Billion-88.82%
2023 -โ‚น57.61 Billion242.73%
2022 -โ‚น16.81 Billion-153.8%
2021 โ‚น31.24 B-20.43%
2020 โ‚น39.26 B278.02%
2019 โ‚น10.38 B27.11%
2018 โ‚น8.17 B-27.12%
2017 โ‚น11.21 B17.21%
2016 โ‚น9.56 B0.45%
2015 โ‚น9.52 B73.51%
2014 โ‚น5.48 B41.36%
2013 โ‚น3.88 B35.2%
2012 โ‚น2.87 B0.4%
2011 โ‚น2.86 B-56.46%
2010 โ‚น6.57 B76.73%
2009 โ‚น3.71 B32.94%
2008 โ‚น2.79 B-5.62%
2007 โ‚น2.96 B
2005 โ‚น4.29 B269.89%
2004 โ‚น1.15 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
โ‚น2.067 T 13,868.54%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚น8.08 B-45.38%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น834.88 B 5,539.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-โ‚น22.95 Billion-255.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.061 T 7,069.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น158.68 B 971.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
-โ‚น1.11 Billion-107.48%๐Ÿ‡บ๐Ÿ‡ธ USA